Our results reinforce these studies: the measured average CHI3L1 concentration in the control group was lower compared to that for high-grade astrocytoma (40.4 ng/mL in low- and 51.1 ng/mL in high-grade astrocytoma (III and IV grade)). This evidence concerns the gene CHI3L1 and astrocytoma (excluding glioblastoma).